Article Text

PDF
Expression of embryonic stem cell markers in keloid-associated lymphoid tissue
  1. Chelsea Grant1,
  2. Daria A Chudakova1,
  3. Tinte Itinteang1,
  4. Alice M Chibnall1,
  5. Helen D Brasch1,2,
  6. Paul F Davis1,
  7. Swee T Tan1,3
  1. 1Gillies McIndoe Research Institute, Wellington, New Zealand
  2. 2Department of Pathology, Hutt Hospital, Wellington, New Zealand
  3. 3Wellington Regional Plastic, Maxillofacial & Burns Unit, Hutt Hospital, Wellington, New Zealand
  1. Correspondence to Dr Swee T Tan, Gillies McIndoe Research Institute, P.O. Box 7184, Newtown, Wellington 6242, New Zealand; swee.tan{at}gmri.org.nz

Abstract

Aims To identify, characterise and localise the population of primitive cells in keloid scars (KS).

Methods 5-µm-thick formalin-fixed paraffin-embedded sections of KS samples from 10 patients underwent immunohistochemical (IHC) staining for the embryonic stem cell (ESC) markers OCT4, SOX2, pSTAT3 and NANOG, and keloid-associated lymphoid tissue (KALT) markers CD4 and CD20. NanoString gene expression analysis and in situ hybridisation (ISH) were used to determine the abundance and localisation of the mRNA for these ESC markers.

Results IHC staining revealed the expression of the ESC markers OCT4, SOX2, pSTAT3 and NANOG by a population of cells within KS tissue. These are localised to the endothelium of the microvessels within the KALTs. NanoString gene expression analysis confirmed the abundance of the transcriptional expression of the same ESC markers. ISH localised the expression of the ESC transcripts to the primitive endothelium in KS tissue.

Conclusions This report demonstrates the expression of ESC markers OCT4, SOX2, pSTAT3 and NANOG by the endothelium of the microvessels within the KALTs. These findings show a unique niche of primitive cells within KS, expressing ESC markers, revealing a potential therapeutic target in the treatment of KS.

  • DERMATOPATHOLOGY
  • HISTOPATHOLOGY
  • IMMUNOHISTOCHEMISTRY
  • SKIN

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.